Consumer-discretionary cyclicality — Fitness/Outdoor are ~61% of revenue and demand can roll over fast
One-line thesis. Garmin is a genuinely excellent, debt-free, high-return niche hardware company (FY25 revenue +15% to $7.25B, 59% gross margin, 20% ROE, $2.1B net cash) — but after a spectacular 2024–25 wearables surge the growth is normalizing back to low-teens, the stock already trades at 27× trailing, and with no expert coverage to lean on, the honest call is Watch, not Buy: own the business, wait for a better price.
◆ Synthos call — WatchGRMN is a business we want at a price we don't have — it becomes a Buy below ~$220; until then, do nothing.
Downside Risk (lower = safer)
4/10 · Moderate
Net-cash fortress & 0.92 beta — but 27× trailing on a low-teens grower and consumer-electronics cyclicality.
Decelerating from the 2024–25 wearables spike; $46B cap in mature end-markets caps the multibagger.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 16%/yrTo justify today’s $240, earnings would have to compound roughly 16% a year for 10 years (9% discount rate). Analysts forecast ~11%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Garmin makes the GPS watches, fitness trackers, boat and airplane electronics, and car navigation you've seen on runners' wrists and in cockpits. It's a really well-run company: it owes almost no money, sits on about $2.1 billion of spare cash, and keeps roughly 23 cents of every sales dollar as profit. Sales grew 15% last year, driven by a boom in its high-end sport watches.
The catch: the stock is priced about right, maybe a touch rich — you're paying roughly 27 years of current profit for it, and the recent growth spurt is cooling back toward a slower, steady pace. So there's no bargain here today, and no famous investors in our research library are pounding the table for it. Our verdict is Watch — a good company to keep an eye on and buy on a dip, not to chase at today's price.
Here's what our three scores mean in everyday terms:
Downside Risk 4/10 (fairly safe). The balance sheet is a fortress and the stock isn't especially jumpy — but it sells discretionary gadgets, so in a recession sales can drop, and the price isn't cheap.
Growth Quality 6/10 (good). Solid, profitable, well-run — just growing at a steady low-teens pace, not on fire.
Exponential Potential 3/10 (low). Its markets are mostly mature and it's already a big company, so don't expect it to multiply several times over.
The one big worry: most of Garmin's money comes from things people buy when they feel flush — premium watches and outdoor gear. If wallets tighten, those sales can fall quickly.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLK (sector)), set to 100 a year ago
Solid = GRMN · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$239.96
Market cap$46B
P/E trailing10×
P/E FY26E / FY27E25× / 23×
EV / Sales5.9×
EV / EBITDA19.3×
Gross margin59.1%
Net margin23.3%
Dividend yield1.56%
Beta0.918
52-wk range$187 – $268
RSI(14)52
50 / 200-DMA$239 / $229
12-mo return+14% (SPY +21%)
Street target$271 ($238–$325)
Analyst grades5 Buy · 20 Hold · 2 Sell
FMP ratingA-
Next earnings2026-08-05
What the experts actually said 0 traceable claims on GRMN · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Garmin Ltd. (NYSE: GRMN) is a Schaffhausen, Switzerland-headquartered designer and manufacturer of GPS-enabled and wireless consumer and professional electronics, founded in 1989 and public since 2000. It runs five reporting segments and is unusually diversified for a hardware company — no single segment is more than ~33% of revenue. Fiscal year ends late December.
Revenue mix (FY2025, from FMP segmentation):
By segment: Fitness $2.357B (33%) · Outdoor $2.054B (28%) · Marine $1.183B (16%) · Aviation $0.987B (14%) · Automotive/Auto OEM $0.665B (9%). Fitness + Outdoor together are ~61% of revenue and are the most consumer-discretionary (and cyclical) piece; Aviation and Marine are stickier, higher-margin professional/prosumer franchises.
By geography: Americas $3.454B (48%) · EMEA $2.742B (38%) · Asia Pacific $1.050B (14%). Notably less US-concentrated than most S&P peers — a real diversification strength, but it adds FX exposure.
The story of the last two years is the Fitness segment surge: high-end wearables (fenix, Forerunner, epix, Instinct lines) drove Fitness from $1.34B (2023) to $1.77B (2024) to $2.36B (2025) — a 76% two-year jump that powered the whole company's re-rating. The strategic question (see §4) is how much of that was a durable share/ASP gain versus a replacement-cycle bulge.
2. The expert thesis — why the panel is bullish (traceable)
There is none to report. The Synthos knowledge base contains zero distilled expert claims for GRMN (total_claims: 0, net_bullish_voices: 0, empty top array). No net-bullish voices, no cautionary voice, nothing to reconcile to a claim_id.
This matters for how you read everything below. Synthos's highest-conviction calls (e.g. our Buy — Core names) are backed by a broad panel of independent, skill-weighted expert voices whose every claim reconciles to a real ID. GRMN has none of that. The verdict here is therefore explicitly fundamentals- and quant-driven only — built from FMP financials, analyst estimates, and management's own SEC-filed guidance. We will not manufacture conviction we do not have: absence of expert coverage is itself a reason to size smaller and demand a wider margin of safety, and it is a direct input into the Watch verdict rather than a Buy.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
4 · Low-Moderate
Net-cash balance sheet ($2.1B net cash, net-debt/EBITDA −0.9×), 0.92 beta and only −10% off highs make it sturdy — but 27× trailing on a low-teens grower, plus discretionary/consumer-electronics cyclicality, cap how safe it is.
Growth Quality
6 · Good
~12% forward EPS CAGR, 59% gross margin, 20% ROE / 17% ROIC, and durable niche moats — a genuinely well-run compounder, just not a hyper-grower.
Exponential Potential
3 · Low
Growth is decelerating off the 2024–25 wearables spike (FY25 +15% → ~11% forward), end-markets are mostly mature, and a $46B cap in these TAMs limits any multibagger path.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Wearables strength proves durable, Aviation/Marine keep compounding, margins hold ~60% GM. FY27E EPS beats to ~$11.5 (vs $10.45 cons); multiple re-rates to ~28× on proven durability.
~$320 (+33%)
Base(our anchor)
Estimates roughly hit — FY26E EPS $9.64, FY27E $10.45; a steady low-teens compounder with a fortress balance sheet earns a ~24× multiple on FY27E.
~$250 (+4%)
Bear
Wearables replacement bulge fades, consumer discretionary softens, FY27E EPS stalls near $9; multiple de-rates to ~19× as the growth premium evaporates.
~$175 (−27%)
Synthos fair value = the base case, ~$250 (+4%), with the full $175–$320 span as the honest range. Our base sits below the Street's $271 consensus — we are less willing to extrapolate the 2024–25 wearables surge, and the Street itself is only a Hold (20 of 28 analysts). Note the Street's low target ($238) is essentially today's price, telling you even the bears see limited downside from fundamentals — the debate is about how much upside is left. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). GRMN is a quality compounder that has just passed its acceleration peak:
Acceleration (the 2nd derivative) is negative: revenue growth was +8% (FY23) → +30% Fitness-led surge peaking in 2024–25 (+15.1% total FY25) → ~10.6% (FY26E) → ~10.1% (FY27E). The wearables inflection already happened; from here Garmin decelerates toward a steady low-teens grower. Per our flagship philosophy we favor forward next-exponentials over trailing compounders — GRMN is firmly on the compounder side, and past its steepest slope.
Room to run: the addressable markets (fitness wearables, outdoor, marine electronics, general-aviation avionics, auto OEM infotainment) are real but mature and fragmented, and Garmin already holds strong share in most. At $46B it is not capacity-constrained on demand the way a small disruptor is — but neither is there a $500B TAM to grow into. A 5× from here implies a ~$230B company in these end-markets, which strains credulity.
Reinvestment runway: disciplined, modest capex (~$270M/yr, ~4% of revenue) and heavy R&D (~15% of revenue) — a healthy innovation engine, but not a hyper-scaling reinvestment story.
Exponential Potential: Low (3/10). Own GRMN for durable ~12% earnings compounding + a fortress balance sheet + a growing dividend — not for a fast multibagger. This is the honest framing, and it is why GRMN sits in a quality-at-a-fair-price bucket, not the exponential tier.
Revenue: FY25 $7.25B, +15.1% (FY24 $6.30B, +20.4% on FY23 $5.23B). Strong, but the growth rate is normalizing after the 2024 peak.
Quarterly trajectory: Q1'25 $1.535B → Q2 $1.815B → Q3 $1.771B → Q4 $2.125B → Q1'26 $1.753B (+14.2% YoY). Growth is steady in the low-to-mid teens; note the pronounced Q4 seasonality (holiday wearables).
Margins: gross 59.1% TTM (best-in-a-decade, up from ~57%), operating ~26%, net 23.3% TTM. Margin expansion is a genuine positive — a favorable mix shift toward high-margin Fitness/Aviation and operating leverage.
Earnings: net income $1.664B FY25 (+17.9% vs $1.411B FY24); diluted EPS $8.59 vs $7.30. Q1'26 net income $405M, EPS $2.09 (+22% YoY GAAP).
Balance sheet (the standout):$2.74B cash & short-term investments, essentially no financial debt (only $165M of lease obligations), net cash ~$2.1B, net-debt/EBITDA −0.9×, current ratio 4.4×. This is one of the cleanest balance sheets in the S&P 500 — it removes financial risk almost entirely and funds a rising dividend plus buybacks with room to spare.
6. Valuation — priced in or room?
GRMN is not cheap, not egregious — fairly-to-fully valued. Trailing metrics: 27× EPS, 5.9× EV/sales, 19.3× EV/EBITDA, ~32× P/FCF. On forward consensus the P/E is ~25× (FY26E) → ~23× (FY27E) → ~20× (FY28E) — the multiple compresses only gradually because earnings grow only ~12%, so this is not a case of "growth outrunning the multiple" the way it is for a 25%+ grower. The PEG is ~1.5–3×, which for a low-teens grower is full. Backing out a reverse-DCF: today's ~$240 implies the market is paying a modest premium for balance-sheet quality and margin durability on top of low-teens growth — reasonable, but leaving little margin of safety. Street targets (context): consensus $271, high $325, low $238, median $249 — and the sell-side is itself only a Hold (20 of 28). Our $250 base is a hair below consensus and near the median, reflecting our reluctance to extrapolate the wearables bulge. A quality-company-at-a-fair-price, not a bargain.
7. Technicals (from the FMP tech block)
Trend:neutral-to-mildly-constructive. $240 sits right at the 50-DMA ($239.5) and above the 200-DMA ($228.7) — the 50 above the 200 is a mild uptrend posture, but price is not extended. MACD −0.40 (marginally negative / flat).
Location:−10.3% off the 52-week high ($267.52) and +28% off the 52-week low ($187.10) — mid-range, not near either extreme; max drawdown from peak a modest −10.3%.
Momentum: RSI(14) 52 — dead neutral, neither overbought nor oversold. No stretched-entry signal in either direction.
Relative strength (a mild negative): GRMN +13.7% 12-mo vs SPY +20.6% and QQQ +30.3% — it has lagged both the market and the Nasdaq over the past year. 6-mo it's ahead of SPY (+17% vs +8%) but 3-mo it's flat (+1% vs SPY +14%, QQQ +22%). Recent momentum has cooled.
Read: technicals are neutral and consistent with the fundamental call — no urgency to buy at $240, no technical breakdown either. A pullback toward the 200-DMA (~$229) or the low-$200s would be a more attractive entry for a quality holding.
8. Moat & competitive position
Garmin's moat is narrow-but-real and unusually diversified: (1) brand and ecosystem in premium sport/outdoor wearables (Garmin Connect, Connect IQ, multi-year battery life, sport-specific depth that Apple/Samsung's general-purpose smartwatches don't match); (2) high-margin professional franchises in Aviation (integrated cockpit avionics, Autoland — genuinely certified, sticky, high-barrier) and Marine (chartplotters, sonar, trolling motors) where competition is limited and switching costs are high; (3) vertical integration and manufacturing scale that supports 59% gross margins. The chief competitive threats are Apple/Samsung/Chinese wearable makers pressing on the Fitness segment, and the inherent cyclicality of consumer discretionary demand. Aviation and Marine are the durable moats; Fitness is the growth engine but also the most contested.
Peer set (FMP-supplied, market cap): the list FMP returns is a grab-bag of tech-hardware names rather than true product comps — Celestica $39B, Cognizant $20B, Ericsson $36B, Fair Isaac $29B, Flex $50B, Keysight $54B, Monolithic Power $63B, Nokia $65B, Sandisk $258B, Teledyne $30B. None is a real Garmin competitor (its actual comps are Apple/Samsung in wearables and niche avionics/marine players); treat this peer set as sector-bucket context only. On growth-adjusted quality (59% GM, 20% ROE, net cash), Garmin screens better than most of this list.
9. Management, capital allocation & guidance
Leadership: President & CEO Clifton Pemble (a long-tenured operator) and Executive Chairman Min Kao (co-founder, still a large holder — ~30M+ shares across accounts). Founder-aligned ownership is a governance positive.
Capital allocation: conservative and shareholder-friendly. Modest capex (~4% of revenue), a rising dividend ($3.75/share TTM; Board recommending $4.20/share for 2026, ~1.6–1.7% yield, ~40% payout), and a $500M buyback authorization through 2028 ($491M remaining as of Q1'26). No debt-funded financial engineering — buybacks and dividends are funded comfortably from FCF while net cash keeps building.
Insider activity: the recent Form 4s are almost all gifts (G), awards (A), and in-kind tax withholding (F) — routine estate/compensation mechanics, plus one tiny director sale (643 shares at $236). No alarming discretionary selling in the sampled window.
Management's own guidance (half-weighted — their book): per the SEC 8-K earnings release filed 2026-04-29 (Q1'26), management maintained full-year FY2026 guidance of ~$7.9B revenue and pro forma EPS of ~$9.35. CEO Cliff Pemble framed it as "a continuation of the positive trends… over the long term," citing the "highly diversified business model." This is management's self-interested framing and we discount it accordingly — but the guidance is consistent with (slightly below) the Street's ~$8.01B / $9.64 GAAP-basis estimate, so it does not flag a disconnect.
10. Catalysts & what to watch
Next earnings: 2026-07-29 (Q2'26; Street EPS $2.27, revenue ~$1.93B). The key line: Fitness segment growth — is the wearables strength durable or is the replacement bulge fading?
Holiday wearables cycle (Q4): the seasonally huge quarter; new fenix/Forerunner/epix refresh reception drives the print.
Margin trajectory: whether the 59% gross margin holds or mix reverts — the re-rating rests on margin durability.
Aviation & Marine momentum: the sticky, high-margin franchises (Autoland certifications, new avionics/sonar launches) — the quality ballast.
Consumer-discretionary macro: the single biggest swing factor for Fitness/Outdoor demand.
Thesis tripwires (what would change the call): two consecutive quarters of Fitness revenue decline; gross margin slipping back below ~56%; management cutting FY guidance; or a de-rating below ~20× that would flip this from Watch to Buy.
11. Key risks
Consumer-discretionary cyclicality (structural): Fitness + Outdoor ~61% of revenue are premium discretionary purchases; a consumer slowdown hits them fast and the 2024–25 surge raises the bar for comparisons.
Wearables replacement bulge: much of the recent Fitness growth may reflect a device-refresh cycle that could normalize, making forward comps hard.
Big-tech competition: Apple, Samsung, and low-cost Chinese entrants continue pressing on the wearables segment — Garmin's defense is sport-specific depth and battery life, not scale.
Valuation / de-rating: 27× trailing on ~12% growth leaves little margin for a demand or margin disappointment.
FX exposure: 52% of revenue is non-US (EMEA + APAC), so a strong dollar is a real headwind to reported growth and margins.
No expert coverage: the Synthos KB has zero traceable claims here — this call has no independent conviction backstop and rests entirely on fundamentals/quant. That is itself a reason for caution and smaller sizing.
12. Verdict, position sizing & monitoring
Watch. Garmin is a genuinely high-quality business — 59% gross margin, 20% ROE, ~$2.1B net cash, a rising dividend, and a rare diversified-hardware moat spanning wearables, aviation, and marine. But three things hold it back from a Buy today: (1) it trades at 27× trailing / ~24× forward on only ~12% growth, so there's little margin of safety; (2) growth is decelerating off the 2024–25 wearables spike; and (3) there is no expert coverage in the Synthos KB to provide independent conviction — and the sell-side itself is only a Hold. This is a company to own on a pullback, not to chase at the current price.
Sizing: if owned at all, a small ~1–2% satellite quality holding — not a table-pounding position at this valuation. A better entry (toward the 200-DMA ~$229 or the low-$200s, or a de-rating below ~20×) would upgrade the case toward Buy — Tactical.
Monitoring: re-underwrite on the tripwires in §10; formal re-score each earnings print (next 2026-07-29). This verdict is logged as a tracked Synthos call as of 2026-07-03 at $239.96.
Single biggest risk: consumer-discretionary cyclicality in the Fitness/Outdoor segments (~61% of revenue) — a demand rollover would hit both growth and the premium multiple at once.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — there is no expert coverage for GRMN in the Synthos knowledge base. This deep dive is explicitly fundamentals- and quant-driven; no conviction is claimed or fabricated. Fabricated conviction is structurally impossible (claim-ID reconciliation), and here there simply are no claims to cite.
Data as-of: fundamentals 2026-03-28 (Q1'26) · estimates 2026-07-03 · prices 2026-07-02. Forward figures are analyst consensus (FMP), labeled as estimates.
Management caveat: FY2026 guidance (~$7.9B revenue, ~$9.35 pro forma EPS) is management's own book, from the 2026-04-29 SEC 8-K (Item 2.02), and is half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").